Resultados: 295

    WHO guidelines for the treatment of neisseria gonorrhoeae

    Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...

    Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

    In this new consolidated guidelines document on HIV prevention, diagnosis, treatment and care for key populations, the World Health Organization brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other close...

    WHO guidelines on the management of health complications from female genital mutilation

    These guidelines are intended primarily for health-care professionals involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This document also provides guidance for policy-makers, health-care managers and others in charge of planning, developing a...

    Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

    The field of HCV therapeutics continues to evolve rapidly and, since the World Health Organization (WHO) issued its first Guidelines for the screening, care and treatment of persons with hepatitis C infection in 2014, several new medicines have been approved by at least one stringent regulatory authority...

    Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach

    These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and car...

    Personal protective equipment for use in a filovirus disease outbreak: rapid advice guideline

    Filoviruses (Ebola and Marburg) are highly contagious pathogens, which cause severe and often fatal illness in humans. Health workers are at increased risk of infection with these viruses because of their close and prolonged contact with severely ill patients with a high viral load. The risk of transmiss...

    Clinical Practice Guideline of Acute Respiratory Distress Syndrome

    Korean j. intern. med; 79 (4), 2016
    Since the first description of acute respiratory distress syndrome (ARDS) as a series of 12 patients in 1967 by Ashbaugh et al.1 , it still remains a major public health problem that incurs high health care costs and causes major mortality in the intensive care unit (ICU) despite improvements in outcomes...

    Guía de práctica clínica basada en la evidencia para el uso de componentes sanguíneos (Adopción)

    Promover en los profesionales de salud una buena práctica clínica en el uso de los componentes sanguíneos, en la baja, mediana y alta complejidad. · Proponer criterios para facilitar la toma decisiones en relación a las indicaciones de transfusión, y de esta manera reducir la variabilidad clínica ...

    Guía de práctica clínica sobre diagnóstico y tratamiento de Hepatitis B Crónica Adopción

    Emitir recomendaciones basadas en la mejor evidencia científica disponible para laprevención, diagnóstico, tratamiento y seguimiento de los individuos adultos residentes en Colombia con hepatitis B crónica; con el propósito de disminuir la morbilidad, mortalidad, discapacidad, comorbilidad infeccios...

    Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level

    Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least one HAI...